Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod
- 28 October 1999
- journal article
- Published by Elsevier
- Vol. 44 (1) , 31-42
- https://doi.org/10.1016/s0166-3542(99)00052-2
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Treatment of Recurrent Genital Herpes with Interferon Alpha-2αGynecologic and Obstetric Investigation, 1998
- Increased Genital Shedding of Herpes Simplex Virus Type 2 in HIV-Seropositive WomenAnnals of Internal Medicine, 1995
- Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigsVaccine, 1995
- Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion developmentAntiviral Research, 1993
- Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex virusesVirology, 1991
- Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infectionsAntimicrobial Agents and Chemotherapy, 1989
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- ISOLATION AND CHARACTERISATION OF RESISTANT HERPES SIMPLEX VIRUS AFTER ACYCLOVIR THERAPYThe Lancet, 1982
- Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistanceNature, 1981
- Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.Proceedings of the National Academy of Sciences, 1980